Abstract
Natural phenolic compounds have been reported to directly inhibit influenza virus. Nonetheless, there have been no reports on the direct inhibitory effects of coffee ingredients. Here, we fractionated the hydrophobic and hydrophilic components of coffee. The hydrophobic fraction directly inhibited both a seasonal influenza A/Puerto Rico/8/24(H1N1) virus and a neuraminidase-resistant influenza A/Yokohama/77/2008(H1N1) virus infection in a dosedependent manner, while the hydrophilic fraction did not show any inhibitory effects, even at concentrations above 100 μg/ml. The HPLC profile of the hydrophobic fraction indicated that caffeine is the major component. Indeed, caffeine alone showed comparable anti-influenza virus activity. Interestingly, caffeic acid also inhibited viral infection, while chlorogenic acid, which is an ester of caffeic acid and (-)-quinic acid, showed no obvious antiviral effect at less than 2 mg/ml. We previously reported a method for enhancing the anti-influenza virus activity of epigallocatechin gallate, a major tea catechin, by lipase-catalyzed acylation. Using this methodology, we synthesized fatty acid esters of caffeic acid and evaluated their influenza virus-inhibitory effects. It was found that dioctanoyl ester of caffeic acid exhibited approximately 38-fold higher direct antiviral activity. To understand the essential structure required for virus inhibition, we further examined the antiviral activity of natural flavonoids containing either the caffeic acid skeleton or its analogous structure. Flavonols (quercetin, myricetin and morin) and hexahydrobenzophenone containing extended planar pi-conjugated systems efficiently inhibited the virus infection. Flavonoids possessing both radical scavenging activity and cytotoxicity tended to show higher antiviral activity, probably due to their affinity with viral surface factors. On the other hand, there was no apparent correlation between their antiviral activity and antioxidative activity. These findings provide insight into the design of anti-influenza virus agents from natural polyphenols.
Highlights
The threat of an influenza virus pandemic is increasing worldwide, highlighting the need for an antiviral agent that is able to inhibit a broad spectrum of viral infection
We reported that epigallocatechin gallate, a major green tea catechin, and its fatty acid derivatives directly inhibit various types of influenza virus including neuraminidase inhibitor resistant viruses [6,7]
The antiviral compounds in the extract were identified as caffeine and caffeic acid
Summary
The threat of an influenza virus pandemic is increasing worldwide, highlighting the need for an antiviral agent that is able to inhibit a broad spectrum of viral infection. Current anti-influenza virus agents mainly target neuraminidase, an enzyme that plays an essential role in the release and spread of progeny virions, following the intracellular viral replication cycle. Previously approved neuraminidase inhibitors can inhibit oseltamivir phosphateresistant viruses [2,3], we must be prepared for outbreaks of novel resistant strains. Green tea catechins have been reported to possess anti-influenza virus activity in vitro [4] and in vivo [5]. We reported that epigallocatechin gallate, a major green tea catechin, and its fatty acid derivatives directly inhibit various types of influenza virus including neuraminidase inhibitor resistant viruses [6,7]. Little is known about the antiviral activity of coffee extracts [10,11], despite its status as the most-consumed drink in the world
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.